Previous close | 6.30 |
Open | 5.42 |
Bid | 5.20 |
Ask | 6.70 |
Strike | 90.00 |
Expiry date | 2024-11-15 |
Day's range | 5.20 - 5.42 |
Contract range | N/A |
Volume | |
Open interest | 101 |
HOLX vs. EW: Which Stock Is the Better Value Option?
BD's (BDX) latest agreement is likely to unlock new future value-creation opportunities and expand its portfolio of smart connected care solutions.
NEW YORK, June 05, 2024--Edwards Lifesciences (NYSE: EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (TAVR) patients with a small annulus. Through five-year follow up of more than 1,300 low and intermediate risk SAPIEN 3 valve patients there were excellent clinical outcomes and valve durability irrespective of the patient’s annulus size or sex. These data were presented during the late-breaking clinical